Table 1.
Clinical, laboratory and demographic characteristics of patients.
| Characteristics | Percentile (n/total) | Median |
|---|---|---|
| Sex | ||
| Male | 51.43% (18/35) | – |
| Female | 48.57% (17/35) | – |
| Age | ||
| 25–86 years old | – | 45 years old |
| Clinical disease profile | ||
| Mild | 17.14% (6/35) | – |
| moderate | 28.57% (10/35) | – |
| severe | 31.43% (11/35) | – |
| critical | 22.85% (8/35) | – |
| SARS-CoV-2 RNA positivity index | ||
| Stool | 51.43% (18/35) | 8.01 × 106 GC/g1 |
| Serum | 14.28% (5/35) | 2.03 × 106 GC/mL1 |
| Urine | 5.71% (2/35) | 1.36 × 105 GC/mL1 |
| Risk factors/Comorbidities | ||
| Pregnancy | 58.82% (10/17) | – |
| Obesity | 25.71% (9/35) | – |
| Hypertension | 22.86% (8/35) | – |
| Diabetes mellitus | 17.14% (6/35) | – |
| Cardiopathy | 17.14% (6/35) | – |
| Chronic kidney disease | 14.28% (5/35) | – |
| Age>65 years old | 11.42% (4/35) | – |
| Previous respiratory disease | 11.42% (4/35) | – |
| Cancer | 2.85% (1/35) | – |
1
Viral loads were expressed in genomic copies per milliliter (stool and urine) or gram (stool).